SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, ...
"Being crabby" might have a whole new meaning. A crab's nervous system could help scientists learn what causes single neurons in the human brain to become "out of whack," which can contribute to the ...
A new study from a team of scientists at the University of Michigan, Weizmann Institute of Science and the University of Pennsylvania developed the first full model of the early embryonic central ...
SciSparc Ltd. (NASDAQ: SPRC) stock is surging on Thursday, with a session volume of 58.21 million compared to the average volume of 2.49 million as per data from Benzinga Pro.